INTERWEST VENTURE MANAGEMENT CO - Q4 2017 holdings

$292 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 11 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 10.0% .

 Value Shares↓ Weighting
TSRO  TESARO INC$167,541,000
-35.8%
2,021,7380.0%57.29%
-15.7%
GKOS  GLAUKOS CORP$26,121,000
-22.3%
1,018,3620.0%8.93%
+2.1%
EIGR  EIGER BIOPHARMACEUTICALS INC$22,314,000
+26.8%
1,599,5920.0%7.63%
+66.5%
MGNX  MACROGENICS INC$20,412,000
+2.8%
1,074,3160.0%6.98%
+35.0%
OBLN  OBALON THERAPEUTICS INC$16,217,000
-30.6%
2,453,3380.0%5.54%
-8.9%
HAIR NewRESTORATION ROBOTICS INC$15,437,0003,355,786
+100.0%
5.28%
CDTX  CIDARA THERAPEUTICS INC$9,226,000
-16.1%
1,356,8130.0%3.16%
+10.2%
IVTY  INVUITY INC$6,698,000
-30.3%
1,080,2720.0%2.29%
-8.5%
AGTC  APPLIED GENETIC TECHNOL CORP$5,241,000
-8.9%
1,455,9040.0%1.79%
+19.7%
KALV  KALVISTA PHARMACEUTICALS INC$3,217,000
+44.8%
329,9420.0%1.10%
+90.3%
XENE  XENON PHARMACEUTICALS INC$23,000
-4.2%
8,2930.0%0.01%
+33.3%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-01-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLAUKOS CORP28Q3 202333.0%
EIGER BIOPHARMACEUTICALS INC24Q3 202217.7%
APPLIED GENETIC TECHNOL CORP24Q3 20226.7%
XENON PHARMACEUTICALS INC20Q3 20210.6%
CIDARA THERAPEUTICS INC19Q2 20214.5%
THE REALREAL18Q3 202362.6%
KALVISTA PHARMACEUTICALS INC17Q4 202010.8%
DARE BIOSCIENCE INC16Q3 20230.3%
MACROGENICS INC14Q1 202019.2%
PMV PHARMACEUTICALS INC13Q3 202367.5%

View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.

Latest filings
TypeFiled
1442024-02-27
13F-HR2023-10-20
13F-HR2023-07-21
13F-HR2023-04-27
13F-HR2023-01-31
13F-HR2022-10-25
13F-HR2022-08-02
13F-HR2022-04-13
13F-HR2022-01-25
13F-HR2021-10-19

View INTERWEST VENTURE MANAGEMENT CO's complete filings history.

Compare quarters

Export INTERWEST VENTURE MANAGEMENT CO's holdings